Taylor Wessing advised Essential Pharma on its acquisition of European rights to Colobreathe. International specialty pharmaceutical company, Essential Pharma, has acquired the European rights to Colobreathe...
Essential Pharma’s Acquisition of European Rights to Colobreathe
Tryzens’ MBO
Taylor Wessing advised the Management of Tryzens on its MBO with WestBridge. Tryzens, an esteemed international digital commerce solutions agency, recently achieved a successful management buyout...
LDC’s Minority investment in Sedex
Taylor Wessing advised the management team of Sedex. LDC, a private equity investor within Lloyds Banking Group, recently completed a minority investment agreement with Sedex, a...
abrdn’s £1.5 Billion Takeover of interactive investor
Taylor Wessing advised interactive investor’s shareholders on the deal. Global investment company and asset manager abrdn’s £1.5 billion takeover of the UK’s leading subscription-based investment platform,...
Carlyle and PAI Partners’ Acquisition of Theramex
Linklaters and Allen & Overy advised global investment firms Carlyle and PAI Partners, while Latham & Watkins acted for CVC Capital Partners and Theramex. Taylor Wessing...
Inflexion’s Minority Investment in Wood Thilsted
Moalem Weitemeyer has together with lead counsel Taylor Wessing assisted Inflexion on the del. Inflexion announced its minority investment in Wood Thilsted, a leading global offshore...
abrdn plc’s £1.49 Billion Acquisition of Interactive Investor
Macfarlanes advised private equity firm J.C. Flowers & Co on the deal. Taylor Wessing advised interactive investor, and Carey Olsen acted for the shareholders. Slaughter and...